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Auditory oddballThe effects of caffeine are mediated through its non-selective antagonistic effects on adenosine A1 and A2A
adenosine receptors resulting in increased neuronal activity but also vasoconstriction in the brain. Caffeine,
therefore, can modify BOLD FMRI signal responses through both its neural and its vascular effects depending
on receptor distributions in different brain regions. In this study we aim to distinguish neural and vascular
inﬂuences of a single dose of caffeine in measurements of task-related brain activity using simultaneous
EEG–FMRI. We chose to compare low-level visual and motor (paced ﬁnger tapping) tasks with a cognitive
(auditory oddball) task, with the expectation that caffeine would differentially affect brain responses in rela-
tion to these tasks. To avoid the inﬂuence of chronic caffeine intake, we examined the effect of 250 mg of oral
caffeine on 14 non and infrequent caffeine consumers in a double-blind placebo-controlled cross-over study.
Our results show that the task-related BOLD signal change in visual and primary motor cortex was signiﬁ-
cantly reduced by caffeine, while the amplitude and latency of visual evoked potentials over occipital cortex
remained unaltered. However, during the auditory oddball task (target versus non-target stimuli) caffeine
signiﬁcantly increased the BOLD signal in frontal cortex. Correspondingly, there was also a signiﬁcant effect
of caffeine in reducing the target evoked response potential (P300) latency in the oddball task and this
was associated with a positive potential over frontal cortex. Behavioural data showed that caffeine also im-
proved performance in the oddball task with a signiﬁcantly reduced number of missed responses. Our results
are consistent with earlier studies demonstrating altered ﬂow-metabolism coupling after caffeine adminis-
tration in the context of our observation of a generalised caffeine-induced reduction in cerebral blood ﬂow
demonstrated by arterial spin labelling (19% reduction over grey matter). We were able to identify vascular
effects and hence altered neurovascular coupling through the alteration of low-level task FMRI responses in
the face of a preserved visual evoked potential. However, our data also suggest a cognitive effect of caffeine
through its positive effect on the frontal BOLD signal consistent with the shortening of oddball EEG response
latency. The combined use of EEG–FMRI is a promising methodology for investigating alterations in brain
function in drug and disease studies where neurovascular coupling may be altered on a regional basis.
© 2012 Elsevier Inc.Open access under CC BY license.Introduction
In the brain caffeine acts as a nonselective antagonist of A1 and A2A
adenosine receptors (Dunwiddie and Masino, 2001). Increased neu-
ronal activity is mediated through action on A1 and A2A adenosine re-
ceptors, while vasoconstriction and as a consequence, reduction in
cerebral blood ﬂow (CBF), is mediated through action on A2A recep-
tors. Caffeine, therefore, can have both neural and vascular effects
depending on the ratio of A1 and A2A receptors in different brain re-
gions (Chen and Parrish, 2009a; Laurienti et al., 2003). In addition,y, Park Place, Cardiff University,
 license.there is also evidence showing that caffeine has secondary effects
on other neurotransmitter systems including dopamine, acetylcho-
line and noradrenaline (Ferre, 2008; Fredholm et al., 1999; Latini
and Pedata, 2001).
Previous studies (Mulderink et al., 2002) have investigated the ef-
fect of caffeine on resting and sensorimotor BOLD activation and have
demonstrated that caffeine decreases resting perfusion (Cameron et
al., 1990) consistent with its vasocontrictive effect. Caffeine can
alter the BOLD contrast arising from task-related changes in brain ac-
tivity. The direction of modulation, however, varies among studies
(Laurienti et al., 2003; Liau et al., 2008; Mulderink et al., 2002). The
complex inﬂuence of caffeine is likely to arise from a combination of
altered baseline blood ﬂow, and hence modiﬁed baseline BOLD signal
from which changes are measured, changes in the brain's resting
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blood ﬂow and metabolism (Chen and Parrish, 2009b; Griffeth et al.,
2011). These factors are likely to be further inﬂuenced by the caffeine
dose administered (Chen and Parrish, 2009a). It has been argued that
the magnitude of the BOLD signal can decrease or increase due to caf-
feine, because of a combination of vascular and neural inﬂuences, the
net effect of which depends on factors such as receptor number and
afﬁnity (Laurienti et al., 2003). Laurienti et al. (2002) demonstrated
that the effect of caffeine on the changes in the BOLD signal depends
on the individual habitual caffeine intake of the volunteers taking part
in the study, with greater positive BOLD signal changes being ob-
served in high compared to low caffeine users (Laurienti et al., 2002).
A few FMRI studies have investigated the effects of caffeine on
cognitive functions (Bendlin et al., 2007; Koppelstaetter et al.,
2008). For example, Koppelstaetter et al. (2008) showed that caffeine
selectively modulated the BOLD signal in frontal cortex during a ver-
bal working memory task in a sample of acutely caffeine abstinent in-
dividuals; there was a signiﬁcant caffeine effect on the bilateral
medial frontal cortex extending to the right anterior cingulate.
These brain regions are associated with attentional and executive
functions such as motivated attention, error detection, planning and
problem solving (Carter et al., 1999; Lawrence et al., 2003; Liu et al.,
2003).
Electrophysiological studies of the effect of caffeine on the central
nervous system have demonstrated spectral shifts towards higher
frequency. A signiﬁcant reduction after caffeine administration of
power in the lower alpha or theta bands (6–10 Hz) has been observed
by several studies (Barry et al., 2005; Bruce et al., 1986; Dimpfel et al.,
1993). This evidence supports the neural stimulating effects of caf-
feine but effects on speciﬁc cognitive activities cannot easily be distin-
guished using resting-state electroencephalography (EEG) measures.
Event-related potentials (ERPs), however, are more appropriate to in-
vestigate the effects of caffeine on the organisation and timing of cog-
nitive processes in the brain during performance of a speciﬁc task.
The effects of caffeine on cognitive and motor function have been ex-
amined in several investigations (Deslandes et al., 2005; Rees et al.,
1999; Ruijter et al., 2000a) in an attempt to clarify possible mecha-
nisms involved. Caffeine's effects on attention, mood and alertness
have been reported (Rogers and Smith, 2011; Rogers et al., 2010;
Ruijter et al., 2000a, 2000b). In addition, changes in the latency and
amplitude of the ERP component, P300, (Deslandes et al., 2004; Pan
et al., 2000; Ruijter et al., 2000a) have been related to the modulatory
effects of caffeine.
The present study investigated the neurocognitive effects of a sin-
gle dose of caffeine using simultaneous EEG–FMRI in an attempt to
identify both general vascular and speciﬁc neural effects of caffeine.
The study aimed to determine the effect of caffeine on non and infre-
quent caffeine consumers during performance of visual, motor and
cognitive (auditory oddball) tasks. Non and infrequent consumers
were selected to avoid inﬂuences of the effects of frequent caffeine in-
take (Rogers et al., 2010). As has been shown by Lorist et al. (1994)
the cognitively beneﬁcial effect of caffeine is larger in a task condition
in which the targets are temporally unpredictable, hence the choice of
auditory oddball (Lorist et al., 1994). We used visual and (paced)
motor tasks as control tasks to identify general vascular inﬂuences
and thus identify the speciﬁcity of effects of caffeine on brain re-
sponses in relation to cognitive performance. In order to monitor
the neurophysiological responses we employed simultaneous FMRI
and EEG enabling us to perform measurements of cerebral haemody-
namic response and cortical electrical activity. Whilst the neurocogni-
tive effects of caffeine have been investigated using these techniques
independently, they have not previously been utilised in combination
to assess such effects in the same subject and in the same environ-
ment. In addition to EEG and BOLD FMRI, arterial spin labelling mea-
surements of cerebral blood ﬂow were obtained to indicate caffeine's
inﬂuence on the perfusional state of the brain.Based on recent evidence (Koppelstaetter et al., 2008) we hypoth-
esized that caffeine might selectively, in comparison with the visual
sensory and the motor task, increase the task-related BOLD signal in
frontal cortex associated with the effects of caffeine on mental perfor-
mance related to attention and executive functioning during the audi-
tory oddball task. Alongside this we anticipated that caffeine may
have a differential effect on the event related potentials (ERPs) elicit-
ed by the oddball task, compared to the low-level sensory (visual)
task.
Materials and methods
Participants
Fourteen healthy, non or infrequent (≤36 mg/day, equivalent to the
caffeine present in a single cup of tea) caffeine consumers, right handed
male volunteers (aged 20–32 years, mean age 25.7±4) were recruited
for the study under the following inclusion criteria: no history of dia-
betes, brain injuries, hypertension, any psychiatric or neurological
disease, alcohol or drug abuse, no use of tobacco products. Information
on participants' caffeine intake over the 8 weeks preceding testing was
recorded during the week preceding testing using a caffeine intake
questionnaire that assessed the frequency of consumption of chocolate,
teas, coffees, colas and other caffeine-containing drinks and dietary sup-
plements (Heatherley et al., 2006b). Weekly caffeine intake was calcu-
lated from these self-report data using dietary and manufacturers'
information on caffeine content (Heatherley et al., 2006a), and this
was conﬁrmed with participants on arrival at each FMRI session. The
study was approved by the local ethics committee. Written informed
consent was obtained from each participant. All participants were free
of medication at the time of scan sessions.
Experimental design and caffeine administration
Caffeine is absorbed in the stomach and small intestine. The peak
concentration in plasma is reached 30–90 min after oral ingestion and
the half-life of caffeine varies from 4 to 8 h depending on body mass,
age, concurrent medications and liver function. The hydrophobic
properties of caffeine allow its passage through all biological mem-
branes. The blood brain barrier is permeable to caffeine and, after
reaching peak absorption, brain levels of caffeine remain stable for
approximately 60–80 min (Fredholm et al., 1999; Nehlig and Boyet,
2000).
Each participant was scanned twice (baseline placebo/caffeine,
BP/BC respectively, followed by a caffeine/placebo scan, DC/DP re-
spectively) on each of two separate visits at the same time of the
day at least one week apart. On each visit participants were scanned
once with the stimulus paradigm described below, removed from
the magnet at which point they received an oral dose of either a gel-
atine capsule containing 250 mg caffeine or placebo (cornﬂour) then
scanned again 30 min later (see Fig. 1). Caffeine was given in a
double-blind, crossover, placebo-controlled, manner. A moderate caf-
feine dosage (250 mg, equivalent to the caffeine present in 2 cups of
ground coffee) was chosen to reﬂect caffeine intake of common
drinking habits. At the end of the second scanning session partici-
pants were asked to guess on which day they received caffeine and
on which day they received placebo.
Physiological parameters
Systolic and diastolic blood pressure (mm Hg, non-invasive blood
pressure cuff) and heart rate were recorded at the beginning and at
the end of every scanning session. Partial pressure of end-tidal carbon
dioxide (PETCO2, mmHg) was measured during the MRI session. Each
volunteer wore a nasal cannula through which respiratory gases
were sampled (capnographmodels CD-3A, AEI Technologies, Pittsburgh,
Fig. 1. Experimental design. Each participant was scanned twice (baseline followed by
caffeine/placebo scan) on each of two separate visits at the same time of the day at
least one week apart. On each visit participants were scanned once with the stimulus
paradigm described below (BP baseline placebo or BC baseline caffeine), removed
from the magnet at which point they received an oral dose of either a gelatine capsule
containing 250 mg caffeine or placebo (cornﬂour) then scanned again 30 min later
(scans DC or DP respectively). Caffeine was given in a double-blind, crossover
placebo-controlled, manner.
241A. Diukova et al. / NeuroImage 62 (2012) 239–249PA, USA). Continuous logging of the PCO2 waveform (CED 1401, Spike 2
Software, CED, Cambridge UK) was performed and PETCO2 was calculated
for each breath using Matlab (The MathWorks Inc. Natick, MA). Mean
PETCO2 was calculated for each subject during an 8-minute period with-
out stimulus presentation towards the beginning of each scan session.
Tasks
Participants were presented with 3 different tasks: a visual task, a
simple paced-motor (ﬁnger tapping) task and an auditory oddball
task while simultaneous EEG and whole-brain FMRI recordings
were made. Participants were trained on the tasks before entering
the scanner.
Visual task
A black and white square checkerboard, reversing at 4 Hz, with a
red central ﬁxation cross was presented in a block design with ﬁve re-
peats of 40 s stimulation and 20 s of rest. The rest condition was a
dark screen with the same ﬁxation cross. Duration of the task was
5 min and 15 s.
Finger tapping task
A visually cued ﬁnger tapping task was employed for motor acti-
vation. The paradigm was presented in a block design of ﬁve repeats
of 26 s tapping and 26 s rest, duration was 4 min and 45 s. Partici-
pants were instructed to tap the ﬁngers of their right hand on buttons
on the MR compatible response device cued by a series of numbers (1
to 5, representing the ﬁrst digit (thumb) to the ﬁfth digit) which
appeared on the display screen after the command “Tap”. The rate
of the paced tapping was 1 tap per second. During the rest condition,
followed by command “Rest,” the same numbers (1 to 5) were pre-
sented on the screen, but participants were asked just to look at the
presented numbers without tapping.
Auditory ‘oddball’ task
A three-stimulus continuous (20 min) auditory ‘oddball’ task was
utilised to elicit a cognitive response. The frequent standard auditory
stimuli (1 kHz, lasting 100 ms), the rare target auditory stimuli
(1.5 kHz, lasting 100 ms) and the novel auditory stimuli consisting
of noises (e.g. dog barks, whistle, etc.), were presented randomly
via headphones (NordicNeuroLabs electrostatic headphones) with a
mean interstimulus interval (ISI) of 2.05 s (randomized in the range
1.8 to 2.3 s). A total of 576 stimuli were delivered. The target and
novel stimuli each occurred with a probability of 15% of trials, whilst
the standard stimuli occurred with a probability of 70%. Participants
were asked to respond quickly and accurately to the target stimuli
only by pressing the right index ﬁnger button on the MR compatible
response device and to ignore standard or novel stimuli. Behavioural
measures were assessed during the performance of the auditoryoddball task as the time taken to respond to target stimuli (reaction
time for correct responses in ms), number of false alarms and missed
responses (misses).
All tasks were programmed using the integrated software tool
“Presentation” Version 11.3 (http://www.neurobs.com). Stimulus
presentation was triggered by the MR-scanner.
Perfusion measurement
MRI was conducted on a General Electric Excite HDx 3T MRI scan-
ner using an eight-channel receive-only head coil. Preceding the func-
tional tasks, whole brain cerebral blood ﬂow (CBF) was measured
using pulsed arterial spin labelling (PASL) with a proximal inversion
and control for off-resonance effects (PICORE), quantitative imaging
of perfusion using a single subtraction (QUIPSSII), sequence with
gradient-echo echo-planar imaging (GE-EPI) readout (Wong et al.,
1998). Seventy-one tag-control image pairs with 16 axial slices
(3.75×3.75×7 mm voxel resolution, matrix 64×64, with a 1 mm
inter-slice gap) were acquired (TR/TE=2200/19.8 ms, single inver-
sion time with TI1=700 ms at TI2=1350 to 2150 ms from the
most proximal to the most distal slice respectively. A separate single
shot EPI (M0) scan was acquired (TR=∞) with the same parameters
to measure the equilibrium brain tissue magnetisation for calibration
purposes. The signal from deep white matter was measured and the
M0 of blood was estimated from the white matter signal assuming a
ratio of proton density of blood to that in white matter of 1.06
(Wong et al., 1998) and T1 blood=1.7 s (Lu et al., 2004), T2*
blood=0.1 s (Silvennoinen et al., 2003), T2* white-matter=0.047 s
(Wansapura et al., 1999). In-house software was used to convert
the estimate of M0 of blood and the mean difference of the motion-
corrected (MCFLIRT (Jenkinson et al., 2002)) tag-control perfusion
pair time-series to CBF in ml/100 g/min by applying a standard single
compartment model (Wong et al., 1998). Following registration to
the common standard space of the Montreal Neurological Institute
(MNI), region of interest CBF values were extracted for each individ-
ual for global grey matter (deﬁned from the probabilistic map of tis-
sue priors available in the FMRIB software library, www.fmrib.ox.ac.
uk/fsl) and regions identiﬁed from the signiﬁcant caffeine effect on
task-related BOLD signal responses from the visual, motor and audi-
tory tasks.
BOLD FMRI data acquisition
FMRI was performed using GE-EPI with repetition time (TR)=
3000 ms, echo time (TE)=35 ms, ﬂip angle (α=90°), ﬁeld of view=
205 mm, 50 slices parallel to inter-commissural (AC-PC) plane, matrix
size=64×64, slice thickness=3.2 mm, the slices were contiguous
(zero slice gap) with a voxel size of 3.2×3.2×3.2 mm3 covering the
whole brain. A 1×1×1 mm3 T1 weighted structural scan was acquired
to facilitate registration of the functional data to the common standard
space of the MNI.
EEG data acquisition
Continuous EEG data were collected from 30 standard scalp elec-
trodes using the BrainAmp MR, a high-input impedance ampliﬁer
speciﬁcally designed for recordings in high magnetic ﬁelds (BrainPro-
ducts, Munich, Germany). Sintered Ag/AgCl ring electrodes with
built-in 5 kΩ resistors mounted into an electrode cap according to
the 10–20 system (Falk Minow Services, Herrsching, Germany)
were used. One additional electrode was placed below the left eye
and one on the lower back to monitor eyeblinks and electrocardio-
gram, respectively. Electrode impedances were maintained below
10 kΩ before recording began. The MR compatible EEG ampliﬁer
was ﬁxed beside the head coil and powered by a rechargeable
power pack. The subject's head was immobilized using sponge pads.
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recording personal computer placed outside the scanner room. All 32
channels were recorded with FCz as reference. The data were
recorded with a passband of 0.016–250 Hz and a sampling rate of
5 kHz.FMRI data analysis
BOLD FMRI data were analysed for each subject using the FMRIB
Software Library (FSL) version 5.98 (www.fmrib.ox.ac.uk/fsl). Prior
to statistical analysis of BOLD data the following processing was ap-
plied to each subject's time series of FMRI volumes: brain extraction
using BET, motion correction using MCFLIRT (Jenkinson et al., 2002),
spatial smoothing using a Gaussian kernel of full width at half max-
imum 5 mm, and nonlinear high-pass temporal ﬁltering (Gaussian
weighted least squares straight line ﬁtting, with high-pass ﬁlter
cut-off of 90 s for visual and ﬁnger tapping tasks and 60 s for audito-
ry oddball). Single-subject low-resolution functional images were
co-registered to their corresponding high-resolution structural im-
ages, and then co-registered to a standard brain (Montreal Neuro-
logical Institute — 152 template) using FLIRT (Jenkinson and Smith,
2001).
Single-subject time-series statistical analysis was carried out using
a general linear model (GLM) approach with local autocorrelation
correction. The design matrix was generated using a single gamma
haemodynamic response function (HRF) and its ﬁrst (temporal) de-
rivative. For visual and ﬁnger tapping tasks the block functions were
convolved with canonical HRF to generate the model time course
for the conditions (box-car design). For the auditory ‘oddball’ task
the design matrix consisted of an onset vector of target stimuli,
novel stimuli and nontarget stimuli (event related design) also con-
volved with the canonical HRF. In addition six rigid-body motion cor-
rection parameters were entered as confounding covariates to
mitigate the inﬂuence of head motion in the data.
Data from each participant were combined in second (group) level
mixed-effects models using FLAME with automated outlier de-
weighting (Beckmann et al., 2003; Woolrich et al., 2004). To identify
the distribution of activity in each task without inﬂuence of caffeine,
scans from baseline placebo (BP, pre-dose) and baseline caffeine
(BC, pre-dose) scans were combined at the second level to produce
group average baseline activity maps. The effects of caffeine were
identiﬁed from a paired second level analysis separately for each
task: visual, motor and auditory oddball. These analyses modelled
the interaction of the effect of “dosing”, namely baseline pre-dose
(B) or post-dose (D), and the effect of “drug”, namely placebo (P) or
caffeine (C). The interaction is described by the contrast (DC–
BC)–(DP–BP) and represents caffeine's effects controlled by baseline
scans. Both positive and negative interaction effects were examined.
A cluster correction for multiple comparisons was used, with an ini-
tial threshold of Z>2.3, and a whole-brain corrected cluster threshold
of pb0.05 for each condition (Worsley, 2001).
Within the regions of signiﬁcant caffeine-related changes in task-
related BOLD response, percentage task-related BOLD signal changes
were calculated (featquery, www.fmrib.ox.ac.uk/fsl) in each condi-
tion BP, BC, DP and DC and time-course BOLD signal responses were
extracted and plotted for the visual and motor tasks. The time (T50)
to reach 50% of the maximum response for the visual and motor
tasks was estimated for each subject (Liu et al., 2004) following linear
interpolation of the region of interest BOLD time-series data to a new
sampling interval of 0.1 s and averaging across stimulus cycles. The
T50 was tested for an effect of caffeine using 2-way repeatedmeasures
analysis of variance. Identiﬁcation of the T50 was not feasible for the
auditory task because of the smaller BOLD signal changes in response
to the presentation of brief events and hence lower signal to noise
ratio of the BOLD responses.EEG data analysis
Brain Vision Analyzer software (Brainproducts, Germany) was
used for correction of MR gradient and ballistocardiographic (BCG)
artefacts (Allen et al., 1998, 2000). Gradient artefacts were removed
as implemented in Vision Analyzer software by subtracting an arte-
fact template from the data, using a baseline-corrected sliding aver-
age of 20 consecutive volumes. Following scanner artefact removal,
pulse artefact subtraction was applied. This procedure works analo-
gously by averaging EEG signal synchronized to the ECG. Segments
contaminated by artefacts due to gross movements were removed
following visual inspection (maximum total 20% rejected from the
data in a given subject). After removal of any bad channels, all chan-
nels were re-referenced to common average. In order to eliminate
slow drifts and high frequency noise, EEG data were then ﬁltered
with a 0.2 Hz high-pass ﬁlter and a 30 Hz low-pass ﬁlter. The ﬁlters
used were phase-shift-free Butterworth ﬁlters with a 24 dB/octave
slope. ICA was performed on the continuous EEG data using the info-
max algorithm and components representing eye-blink were re-
moved from the data (Srivastava et al., 2005). The data were then
segmented into stimulus-locked segments (for the visual stimulation
100 ms before to 300 ms after stimuli occurred and for the auditory
oddball task 200 ms before to 900 ms after target, novel or non-
target stimuli occurred). Automatic artefact rejection was then per-
formed before response averaging to reject trials contaminated by
residual artefacts. Speciﬁcally, trials with a difference of 100 μV or
greater between the largest negativity and largest positivity, and tri-
als with 60 or more data points in a row with the same value were
rejected automatically. All segments were then baseline corrected
using prestimulus data. Finally, segments were averaged within
trial types to produce single-participant averages, and single-
participant averages were then averaged to produce grand-averages.
Statistical analyses
Values are quoted as mean±standard deviation. Physiological,
behavioural, regional CBF and summary event related potential
(ERP) parameters were analysed using a 2-way repeated-measures
(within subject) analysis of variance (ANOVA) to isolate the caffeine
effect while controlling for between day variations with the inclusion
of the baseline scans. The main factors in the ANOVA were dosing
within scan session i.e. baseline (B) or post-dose (D) scan and drug
i.e. placebo (P) or caffeine (C). The drug effect of interest is given by
the interaction of factors “dosing”×“drug.” Post-hoc two-tailed
paired t-tests were also applied after ANOVA.
Results
Physiological parameters
The bodyweight of recruited volunteers was 76.5±11 kg
(mean±standard deviation) with a range of 57 kg to 100 kg. This
gives a mean dose of 0.306±0.0450 mg/kg with a range from
0.228 mg/kg to 0.4 mg/kg.
Caffeine signiﬁcantly increased systolic blood pressure (2-way
repeated-measures ANOVA) (Table 1). Although the interaction ef-
fect in the 2-way ANOVA did not reach signiﬁcance for diastolic
blood pressure and heart rate, post-hoc comparisons of DC with BC
and DP suggest an increase in both parameters with caffeine admin-
istration. There was no signiﬁcant correlation between bodyweight
and changes in blood pressure and heart rate between the baseline
caffeine (BC) and caffeine (DC) conditions. Good quality PETCO2 re-
cordings were obtained for both scans and both sessions in 9 sub-
jects. There was a signiﬁcant effect of caffeine in reducing PETCO2
(Table 1).
Table 1
Physiological parameters measured during caffeine, placebo and baseline conditions
(mean±standard deviation across subjects).
Conditions Systolic blood
pressure
(mm Hg)
Diastolic blood
pressure
(mm Hg)
Pulse Rate
(beats per
minute)
End-tidal
carbon dioxide
(mm Hg)$
Baseline placebo
(BP)
116±9 63±9 85±10 42.0±13.0
Baseline caffeine
(BC)
115±9 65±9 87±9 41.7±4.6
(BC-BP) −1±10 2±10 2±13 −0.3±11.3
Placebo (DP) 116±8 65±9 88±6 42.4±11.0
Caffeine (DC) 122±11+⁎§ 70±10⁎§ 93±8⁎§ 38.3±4.1+⁎
(DC–DP) 5±7 5±8 6±8 −4.1±10.3
$Results based on 9 out of 14 subjects.
+Signiﬁcant interaction effect of dosing (baseline or post-dose scan)×drug (placebo or
caffeine) in a 2-way repeated-measures ANOVA, pb0.05.
⁎Signiﬁcantly different with respect to baseline caffeine (two-tailed post-hoc paired
t-test pb0.05).
§Signiﬁcantly different with respect to placebo (two-tailed post-hoc paired t-test
pb0.05).
Fig. 2. Signiﬁcant BOLD signal changes in response to the visual task vs, rest. a) shows
the group mean visual task related activity (positive signal change) for the two base-
line scans combined (BP and BC). b) shows the baseline-controlled group difference
between placebo and caffeine administration ((DP–BP)–(DC–BC)) indicating a signiﬁ-
cant reduction in the visual BOLD response. Signal changes were deemed signiﬁcant at
Z>2.3 with a whole brain cluster based correction at pb0.05.
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ceived caffeine and placebo, while six participants did not (not signif-
icantly different from chance).
Behavioural performance for the ‘oddball’ task
The 2-way repeated-measures ANOVA (within-subjects) analysis
revealed that caffeine signiﬁcantly reduced the number of missed re-
sponses to the target oddball stimulus (Table 2). However there was
no signiﬁcant effect of caffeine on the number of false alarms or on re-
action times (Table 2).
FMRI: visual task
The visual stimulation elicited widespread activation (a BOLD re-
sponse) in visual cortex including the occiptal pole, occipital fusiform
gyrus, intracalcarine cortex and lateral occipital cortex (Fig. 2a shows
baseline conditions BP and BC combined). Beyond visual cortex, the
task induced BOLD signal increases vs. rest in bilateral hippocampus,
thalamus, frontal pole, paracingulate gyrus, premotor cortex, pre- and
post-central gyrus and superior parietal lobule. The second level
within-subjects analysis examining the caffeine effect while control-
ling for baseline differences ((DP–BP)–(DC–BC)) revealed that the
BOLD signal change in visual cortex was signiﬁcantly reduced by caf-
feine (Fig. 2b). The peak statistical difference was seen at location
(MNI co-ordinates) x=−6, y=−98, z=−6 mm, in primary visual
cortex. A second cluster of voxels of reduced BOLD signal change lay
in the left superior parietal lobule (Fig. 2b).Table 2
Behavioural performance during the auditory oddball task in caffeine, placebo and
baseline conditions (mean±standard deviation across subjects).
Conditions Reaction time
(ms)
Number
of misses
Number of
false alarms
Baseline placebo (BP) 603±138 4.7±4.1 1.8±1.5
Baseline caffeine (BC) 609±126 4.9±3.8 1.7±1.6
(BC-BP) 6±59 0.1±1.6 −0.1±2.0
Placebo (DP) 599±130 5.4±5.2 2.1±1.4
Caffeine (DC) 598±145 2.7±1.9+⁎§ 1.5±1.2
(DC–DP) 1±81 −2.7±3.0 −0.6±1.5
+Signiﬁcant interaction effect of dosing (baseline or post-dose scan)×drug (placebo or
caffeine) in a 2-way repeated-measures ANOVA, pb0.05.
⁎Signiﬁcantly different with respect to baseline caffeine (two-tailed post-hoc paired
t-test pb0.05).
§Signiﬁcantly different with respect to placebo (two-tailed post-hoc paired t-test
pb0.05).FMRI: ﬁnger tapping task
The ﬁnger tapping task elicited activation in the left sensorimotor
cortex, supplementary motor area, thalamus, putamen and right
superior cerebellum (Fig. 3a shows baseline conditions BP and BC
combined). The second level within-subjects analysis examining the
caffeine effect ((DP–BP)–(DC–BC)) revealed that the BOLD signal
change in left sensorimotor cortex was signiﬁcantly reduced by caf-
feine (Fig. 2b). The peak statistical difference was seen at location
(MNI co-ordinates) x=−50, y=−38, z=56 mm.
The mean task-induced BOLD percentage signal changes for each
scan are shown in Fig. S1a and b for the regions in which caffeine
demonstrated a signiﬁcant effect for the visual and motor tasks re-
spectively. The time-course responses for the block-design tasks, vi-
sual and motor, are illustrated in Figs. S2 and S3. There was no
signiﬁcant caffeine effect on the time (T50, not shown) for the BOLD
response to visual and motor stimulation in these regions to reachFig. 3. Signiﬁcant BOLD signal changes in response to the motor (ﬁnger tapping) task vs
rest. a) shows the group mean motor task related activity (positive signal change) for
the two baseline scans combined (BP and BC). b) shows the baseline-controlled
group difference between placebo and caffeine administration ((DP–BP)–(DC–BC)) in-
dicating a signiﬁcant reduction in the BOLD response. Signal changes were deemed sig-
niﬁcant at Z>2.3 with a whole brain cluster based correction at pb0.05.
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peated measures ANOVA).FMRI: auditory oddball task
Comparison of the target stimuli versus the non-target stimuli was
associated with signiﬁcant hemodynamic activity (shown in Fig. 4a
for BP and BC scans combined) consistent with previous studies
(Kiehl et al., 2001, 2005; Polich, 2003). Supplementary Tables 1S, 2S
and 3S, list the regions in which comparisons target–non-target,
target– novel and novel–non-target yielded signiﬁcant responses in the
baseline scans at the group level. The experimental condition target–
non-target was of primary interest in our analysis, representing the
response to oddball stimuli.
The effect of caffeine in the group level comparison controlling
for baseline variation ((DC–BC)–(DP–BP)) was manifested in the
target vs. non-target experimental condition. There was a signiﬁ-
cantly more positive BOLD response for target vs. non-target stimuli
induced by caffeine in superior frontal gyrus, frontal pole and para-
cingulate gyrus (Fig. 4b). The peak statistical difference was seen at
location (MNI co-ordinates) x=18, y=50, z=34 mm. There was
no signiﬁcant effect of caffeine, either (DC–BC)–(DP–BP) or (DP–
BP)–(DC–BC), on the experimental conditions target–novel and
novel–non-target.
There was no signiﬁcant correlation between bodyweight and the
difference in percentage BOLD signal change between baseline caf-
feine (BC) and caffeine (DC) conditions, within the regions in which
the signiﬁcant effect of caffeine was observed for each of the three
tasks, visual, motor (ﬁnger tapping) and auditory “oddball”.
The mean task-induced BOLD percentage signal changes for each
scan are shown in Fig. S1c for the regions in which caffeine demon-
strated a signiﬁcant effect for auditory oddball (target vs. non-
target) task.Fig. 4. Signiﬁcant BOLD signal changes during the auditory oddball task (target stimu-
lus vs non-target stimulus). a) shows the group mean motor task related activity (pos-
itive signal change) for the two baseline scans combined (BP and BC). b) shows the
baseline-controlled group difference between caffeine and placebo administration
((DC–BC)–(DP–BP)) indicating an increase in BOLD signal with caffeine. Signal changes
were deemed signiﬁcant at Z>2.3 with a whole brain cluster based correction at
pb0.05.EEG: visual task
The occipital electrodes O1 O2 and Oz were used for visual
evoked potential (VEP) analysis. The amplitude was deﬁned as
peak-to-peak difference between the global minimum in the inter-
val 25–90 ms and the global maximum in the interval 80–140 ms.
The latency was deﬁned as the time from stimulus presentation to
the point of maximum positive amplitude within the time window
(Fig. 5). Two-way repeated measures ANOVA to compare the ampli-
tudes and latencies of evoked potentials revealed no signiﬁcant ef-
fect of caffeine through the interaction “dosing”×“drug” (p>0.05)
(Table 3).EEG: auditory “oddball” task
The midline electrodes Fz, Cz and Pz were used for analysis
(Tables 4 and 4S). The response for the target stimulus, the P300 am-
plitude, was deﬁned as the largest positive peak (relative to the
100 ms pre stimulus baseline) within the time window of
300–550 ms post stimulus presentation (Fig. 6). The response for
the novel stimulus, “novelty P300” amplitude was deﬁned as the larg-
est positive peak (relative to the 100 ms pre stimulus baseline) with-
in the time window of 250–500 ms post stimulus presentation. The
response for nontarget stimuli, P200, amplitude was deﬁned as
peak-to-peak difference between the minimum in the interval
90–200 ms and the maximum in the interval 200–450 ms. A scalp
map of the caffeine effect on the “novelty P300” response (compari-
son (DC–BC)–(DP–BP)) is shown in Fig. 6, indicating a fronto-
central positivity at a latency of 442 ms.
The two-way repeated measures ANOVAs applied to event related
potentials revealed a signiﬁcant effect of caffeine on the ERP latency
evoked by target stimuli (pb0.05 for the interaction effect for all
three midline electrodes (Table 4)). However, there was no signiﬁ-
cant effect on the amplitude at these electrodes. Furthermore, there
was also no effect of caffeine on amplitude and latency of evoked po-
tentials elicited by non-target or novel stimuli (Table 4S).
There was no signiﬁcant correlation between bodyweight and
the differences in Target stimulus ERP latency (electrode Cz tested)
between baseline caffeine (BC) and caffeine (DC) conditions.
For each subject a number of stimulus trials was excluded for each
subject from the EEG data because of the signal cleaning procedureFig. 5. Group mean visual evoked potentials (VEPs) recorded during baseline placebo
(BP), baseline caffeine (BC), placebo (DP) and caffeine (DC) conditions (left). The dot-
ted vertical line marks stimulus presentation time. The scalp map for the grand-
average VEP (right). The time point shown is at the peak of the VEP for the participants
performing the visual task (latency 114 ms). The magnitude is indicated by the colour-
bar scale at the bottom.
Table 3
Visual evoked potential (VEP) latency and amplitude variations across conditions and electrodes (O1, Oz, O2). There was no signiﬁcant effect of caffeine on VEP amplitude or la-
tency. (mean±standard deviation across subjects).
Condition Latency (ms) Amplitude (μV)
O1 Oz O2 O1 Oz O2
Baseline placebo (BP) 122±15 120±14 122±14 4.8±2.5 6.1±2.3 5.5±2.5
Baseline caffeine (BC) 118±14 118±15 120±15 5.7±2.4 6.7±2.8 7.0±3.5
(BC–BP) −4±11 −2±8 −2±7 0.8±2.1 0.6±2.1 1.5±2.5
Placebo (DP) 121±17 116±11 118±13 4.9±2.7 5.4±2.8 5.3±2.8
Caffeine (DC) 117±16 114±13 119±14 5.4±2.3 6.5±3.1 6.4±2.7
(DC–DP) −4±14 −1±13 1±12 0.5±1.6 1.2±2.1 1.2±2.1
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ber of visual evoked or auditory oddball trials incorporated in the EEG
analysis (p>0.05 for a 2-way repeated measures ANOVA on trials
remaining after EEG cleaning).
Reductions in perfusion
Arterial spin labelling measurements indicated that cerebral blood
ﬂow was signiﬁcantly reduced across grey matter by caffeine admin-
istration (2-way repeated-measures ANOVA, interaction effect
pb0.001). Comparison of the baseline caffeine (BC) with the caffeine
condition (DC) showed a mean reduction of 19% in grey matter. Per-
fusion changes were further tested in regions of interest deﬁned func-
tionally by the signiﬁcant caffeine effects on the BOLD responses in
the visual, the motor (ﬁnger tapping) and the auditory “oddball”
task described above. These regions respectively showed 30% (visual
cortex, left superior parietal lobule), 34% (left sensorimotor cortex)
and 24% (frontal pole, superior frontal gyrus and paracingulate
gyrus) reductions in CBF (BC vs DC conditions). CBF measurements
are summarised in Supplementary Table 5S. There was no signiﬁcant
correlation (pb0.05) between percentage reductions in global grey
matter CBF (BC vs. DC conditions) and bodyweight of volunteers sug-
gesting that the range of bodyweights did not lead to signiﬁcant var-
iation in drug effect, as indexed by CBF.
Discussion
The present study investigated the effect of a single dose of oral
caffeine on cognitive, visual and motor responses in non and infre-
quent caffeine consumers. Adopting a multimodal approach of simul-
taneous EEG–FMRI enabled the acquisition of functional datasets of
both good spatial and temporal resolution and under the assumption
of a coupling between observable EEG and FMRI responses, allowed
us to demonstrate likely changes, resulting from caffeine ingestion,
in the relationship between task-related electrophysiological activity
and the cerebral haemodynamic response.
In the brain, caffeine is a non-selective antagonist of adenosine
receptors. Its blocking action of A1 and A2A adenosine receptors has
a neuronal excitatory effect (Dunwiddie and Masino, 2001) sinceTable 4
The evoked potential responses for target stimuli in the auditory oddball task: latency and a
viation across subjects).
Condition Latency (ms)
Fz Cz
Baseline placebo (BP) 496±85 508±96
Baseline caffeine (BC) 524±89 532±87
(BC–BP) 28±69 24±69
Placebo (DP) 518±90 523±92
Caffeine (DC) 424±79+⁎§ 437±81+⁎§
(DC–DP) −94±38 −87±36
+Signiﬁcant interaction effect of dosing (baseline or post-dose scan)×drug (placebo or caf
⁎Signiﬁcantly different with respect to baseline-caffeine (two-tailed post-hoc paired t-test
§Signiﬁcantly different with respect to placebo (two-tailed post-hoc paired t-test pb0.05).normally adenosine acts to inhibit release of excitatory neuro-
transmitters (Fredholm et al., 1999). Caffeine has a second effect
of blocking A2A adenosine receptors in the cerebral blood vessels,
resulting in vasoconstriction (Dunwiddie and Masino, 2001). Con-
ventional BOLD FMRI signals are dependent on a change in oxygen
consumption and blood ﬂow. Caffeine has the potential therefore
to inﬂuence the BOLD signal in a complex manner through alter-
ations in neuronal activity and the vascular responsiveness to such
alterations.
FMRI ﬁndings
The vasoconstrictive inﬂuence of caffeine in our low-consuming
cohort is evident through the observed widespread reductions in ce-
rebral blood ﬂow (19% across grey matter). This reduced perfusion is
consistent with previous observations using arterial spin labelling
techniques (Field et al., 2003; Laurienti et al., 2003). In the motor
and visual cortices with caffeine administration we observed reduced
task-induced BOLD responses. However, in frontal areas we observed
a more positive task-induced BOLD signal arising from the auditory
oddball task. This would be consistent with an enhancing effect of caf-
feine on brain areas associated with executive functions. We consider
these regional alterations in BOLD response in the context of previous
studies of altered neurovascular coupling with caffeine.
The overall effect of caffeine on the BOLD signal is likely to depend
on which of the two receptor system effects (A1 vs. A2) dominates. In
subjects or brain regions in which the excitatory effect on task-related
neuronal activity dominates we might expect an enhanced task-
induced BOLD response. Where the vasoconstrictive effect dominates
we might expect a diminished BOLD response. This variability of caf-
feine's inﬂuence on the receptor systems has been suggested as an
explanation for differential effects of caffeine on the BOLD response
according to daily dietary caffeine intake (Laurienti et al., 2002).
Laurienti et al, 2002 suggest that low caffeine users experience
more vasoconstriction than neural excitation, with A2 effects domi-
nating, resulting in an observed reduced visual BOLD response in
low caffeine users that is consistent with our present observations
from the visual and motor task. Laurienti et al, 2002 further suggest
that neural A1 receptors tend to increase more than A2 receptorsmplitude variations across conditions and electrodes (Fz, Cz, Pz). (mean±standard de-
Amplitude (μV)
Pz Fz Cz Pz
521±90 8.4±3.4 8.6±3.7 10.0±4.2
539±86 8.6±4.0 8.8±3.9 10.2±4.4
17±102 0.2±1.7 0.2±2.2 0.2±2.9
525±98 7.9±3.0 8.1±3.8 10.5±3.3
442±83+⁎§ 8.1±3.6 8.4±3.3 10.1±3.3
−83±46 0.2±2.0 0.3±2.7 −0.4±1.9
feine) in a 2-way repeated-measures ANOVA, pb0.05.
pb0.05).
Fig. 6. Group mean evoked response waveforms for the auditory target stimulus, P300,
recorded during baseline placebo (BP), baseline caffeine (BC), placebo (DP) and caf-
feine (DC) conditions (left). The dotted vertical line marks stimulus presentation
time. The group mean scalp map is shown (right) for the baseline-controlled group dif-
ference between caffeine and placebo administration ((DC–BC)–(DP–BP)) at the peak
latency of the response on caffeine (DC) (442 ms).
246 A. Diukova et al. / NeuroImage 62 (2012) 239–249with high caffeine use resulting in enhanced neural responses and
therefore dominating the vasocontrictive inﬂuence. This effect may
explain the enhanced visual BOLD response observed in high caffeine
users (Laurienti et al., 2002) and is consistent with other studies in
which caffeine-consuming volunteers show increases in BOLD signal
contrast (Mulderink et al., 2002). Differences between studies in the
caffeine modulation of BOLD responses may also be compounded
by differences of dose, as non-linear dose effects on BOLD amplitude
have been demonstrated (Chen and Parrish, 2009a). Extending
these explanations of caffeine response variability, we suggest that
relative regional differences of caffeine's effect on the task-induced
neural and vascular responses, mediated by the different receptor
sub-systems, may explain the enhancement of the BOLD response in
the frontal cortex and diminution in the motor and visual cortices in
the present study. Indeed, regional differences in caffeine's neural
and vascular action are likely as levels of adenosine A2A receptors, re-
sponsible for the vasoconstrictive effect of caffeine appear, relative
to widely distributed adenosine A1 receptors, to be lower in the pre-
frontal or frontal cortex (Bauer et al., 2003; Fastbom et al., 1987;
Svenningsson et al., 1997).
The effect of caffeine on the regional BOLD response to stimula-
tion can also be considered from the point of view of underlying
cerebral blood ﬂow and metabolism which give rise to BOLD image
contrast. Recent studies have examined ﬂow-metabolism coupling
in a range of cerebral physiological states in which blood ﬂow is
modiﬁed (Ances et al., 2009; Brown et al., 2003) and speciﬁcally
investigated the inﬂuence of caffeine (Chen and Parrish, 2009b;
Griffeth et al., 2011). The investigations concerned visual and motor
cortex in cohorts containing regular caffeine consumers who were
asked to abstain from caffeine before the study. Both studies show
a decrease in n, the coupling ratio between stimulus-induced frac-
tional changes in CBF and CMRO2, and thus the importance of the
underlying physiological responses. Griffeth et al, 2011, showed
that consideration of absolute changes is important. They showed
in visual cortex a caffeine induced reduction in baseline CBF, a reduction
in task-induced increase in CBF, an increase in baseline CMRO2 and an
increase in task-induced increase in CMRO2. These observations are
consistent with the neural (CMRO2) and vasocontrictive (CBF) caffeine
effects discussed in associationwith A1 and A2A receptors. The net effect
observed by Griffeth et al was no overall caffeine-induced change in
visual stimulus-induced BOLD signal. However, the study makesclear that the modulation of the task-related BOLD response is highly
sensitive to the balance of caffeine-induced changes in underlying and
task-related changes in physiology. The BOLD response could be in-
creased or decreased depending on the relative modulation of the
CMRO2 and CBF response to stimulation. A slightly more attenuated
CBF response would have resulted in a reduction of the overall BOLD
response, as we see in the present study for our visual and motor
tasks. Conversely a slightly less attenuated CBF response would have
resulted in an increase of the overall BOLD response to stimulation, as
we see for our oddball task. Given that in our present study we exam-
ine a low-consuming cohort and are comparing different brain regions
it is likely that the balance of metabolic and perfusion changes may
differ compared to earlier studies. We suggest that dose, cohort and
importantly brain-region based differences in the absolute CMRO2
and CBF responses could contribute to the differential modulation of
our observed BOLD responses between visual and motor cortices and
frontal cortex.
EEG ﬁndings
We examined two commonly reported features of the task-evoked
potentials from the visual and auditory-oddball tasks, amplitude and
latency. Scalp EEG does not reveal all features of evoked neuronal ac-
tivity. We therefore interpret with caution the relationship between
observed evoked potentials and the BOLD signal considering an em-
pirically deﬁned coupling between the two types of measurement of
brain activity.
We saw no signiﬁcant effect of caffeine on VEP latency or ampli-
tude in any of the occipital electrodes. This is consistent with the
study of Owen et al, 2001 (Owen et al., 2001) in an EEG study with
a similar visual stimulus. However in the study by Azcona et al.
(1995) it was shown that caffeine signiﬁcantly increases amplitude
of VEPs but has no effect on the latency. Such differences from the
current experiment could be because of the visual task differences
or the higher caffeine dose used by Azcona and colleagues. The
unchanged VEPs combined with a reduced visual-evoked BOLD re-
sponse suggest an altered empirical neurovascular coupling. This
would be consistent with a preserved neural response and hence ox-
ygen consumption but a reduced CBF response, consistent with the
vasoconstrictive effect of caffeine on the task-induced absolute CBF
response.
In the cognitive auditory oddball task we observed a shorter
latency of the P300 evoked potential induced by target stimuli after
caffeine administration and an improvement in task performance
(signiﬁcant reduction of missed responses). This altered latency is
suggestive of caffeine induced alterations in neuronal activity. How-
ever, no change in evoked amplitude was observed. Our observed
change in latency is consistent with previous examinations of caffei-
ne's effects on neuronal activity. Discrimination between target and
standard stimuli in an oddball task is believed to initiate frontal
lobe activity that is sensitive to the attentional demands induced
by task performance (Polich, 2007). P300 latency is negatively corre-
lated with mental function in healthy subjects and shorter latencies
indicate a superior cognitive performance (Polich, 2007; Polich and
Herbst, 2000). Some studies have pointed to an improvement of
cognitive performance after caffeine ingestion through a signiﬁcant
shortening of P300 latency, especially in the frontal cortex (medial
frontal electrode Fz) (Deslandes et al., 2005; Kenemans and Lorist,
1995; Montenegro et al., 2005; Pan et al., 2000), consistent with
the frontal distribution shown in the scalp maps of Fig. 6. Other stud-
ies have shown an increase in P300 amplitude, which we failed to
ﬁnd, with caffeine (Dixit et al., 2006; Kawamura et al., 1996;
Ruijter et al., 2000a). However, observations of altered amplitude
with caffeine are less consistent as some studies found no changes
(Deslandes et al., 2005; Kenemans and Lorist, 1995) or even a de-
crease (Montenegro et al., 2005; Pan et al., 2000). Barry et al.
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are fairly focal and not widely distributed to all responses, the in-
duced differences beingmore commonly found in later responses re-
lated to task performance and response production rather than
global increases in ERP amplitude which might be expected from
an increase in general arousal. This is consistent with the restriction
of our observed caffeine effects to the P300 latency only for the target
stimulus and with no detected effects on the other auditory stimuli
or the visual evoked potentials.
The altered ERP and BOLD responses in the auditory oddball ex-
periment occur in broadly similar (frontal) brain regions suggesting
a possible link between the shortened latency and the enhanced fron-
tal BOLD response. However, this must be interpreted with caution
because BOLD and ERPs do not necessarily have a one-to-one map-
ping (Logothetis, 2008). The enhanced frontal response to the oddball
task is consistent with previously observed regional functional spe-
cialisation and the improved task performance. Brodmann Area 8 is
believed to positively correlate with management of uncertainty
and expectation, while BA 9 and 10 are part of the dorsolateral pre-
frontal cortex (DLPFC) responsible for motor planning, organisation,
decision making and regulation (Nelson and Luciana, 2001). Cingu-
late cortex is associated with attention, motivation and error detec-
tion. The enhanced frontal response to the oddball task is in strong
agreement with the study of Koppelstaetter et al. (2008) who observed
an enhancing effect of caffeine on task related BOLD response in brain
areas associated with executive functions in a working memory
task, albeit with a lower caffeine dose in moderate consumers.
The shortened latency of the oddball ERP in the present study sug-
gests a neuroexcitatory action of caffeine on brain areas involved in
executive and attentional functions, consistent with the observed
behavioural results. A previous simultaneous EEG–FMRI study of
oddball event-related potentials (P300) (Bénar et al., 2007) demon-
strated a negative correlation between P300 latency and task-
related BOLD signal in the medial frontal cortex. This was revealed
in a single-trial analysis exploiting trial to trial variability in response
latency. In that study, P300 latency also correlated with reaction
times which led to an interpretation of medial frontal cortex being
positively related to task performance. The study of Bénar et al.
(2007), therefore, supports the notion that our observed alteration
of the ERP latency is consistent with the enhanced task-related frontal
BOLD response in the present study. However, further investigation
would be needed to link directly the alterations in EEG and FMRI
responses as the enhanced frontal BOLD response could also be
explained by alterations in vascular behaviour, the effects of caffeine
being a combination of both neural and vascular (Dunwiddie and
Masino, 2001; Haas and Selbach, 2000). Similarly, we cannot rule
out a potential neuroexcitatory effect in visual areas but with a differ-
ent regional effect on the BOLD response, as discussed, due to under-
lying physiological differences between sensory (e.g. visual) and
frontal regions.
Caffeine and neurotransmitter systems
Caffeine has not only a direct effect on adenosine receptors but
also has important secondary effect on other neurotransmitter sys-
tems such as cholinergic, noradrenergic and dopaminergic (Ferre,
2008; Latini and Pedata, 2001). A substantial body of evidence indi-
cates that the prefrontal cortex is involved in processes of cognition
and receives ascending input from different neuromodulatory sys-
tems including dopaminergic (Nelson and Luciana, 2001). As a result
of the inhibition of adenosine A2A receptors by caffeine, transmission
via dopamine D2 receptors is increased (Ferre, 2008; Fredholm et al.,
1999). Together with the indication that caffeine affects the atten-
tional system, dopamine D2 receptors have been demonstrated to
modulate neural networks involved in selective and involuntary at-
tention (Kahkonen et al., 2002). Dopaminergic neurotransmissionmay play an important role in the generation of the P300. This ERP
component is sensitive to dopamine-enhancing drugs in patients
with Parkinson's disease (Stanzione et al., 1991; Starkstein et al.,
1989). In addition, monoaminergic neurotransmitters were found to
supress spontaneous background activity while enhancing cortical
neural responses to a stimulus and focussing neural activity to brain
structures speciﬁc for the processing of particular information (Mattay
et al., 2000). This is in agreementwith our results as we did not observe
signiﬁcant differences in amplitude or latency of EPs evoked by nontar-
get or novel stimuli.
Another neurotransmiter, acetylcholine, may attract attention as
a target of action for caffeine (Ferre, 2008; Fredholm et al., 1999).
For example, Rainnie et al. (1994) demonstrated that caffeine in-
creased ﬁring rates in mesopontine cholinergic neurons, which
have been found to participate in the production of arousal evident
in EEG. These cholinergic neurons are inhibited by adenosine, pro-
viding a coupling mechanism linking EEG arousal and caffeine.
This is strong evidence for the role of caffeine in the behavioural
state of arousal.
Methodological considerations
The EEG has the advantage of providing us with an electrophysio-
logical measure which is thought not to be inﬂuenced directly by the
state of the vasculature. We chose to perform EEG and FMRI simulta-
neously, whereas, it would have been possible to conduct them in
separate sessions and to avoid the potential compromise in quality
of simultaneously acquired EEG and FMRI data. For a pharmacological
study such as this, the advantage of simultaneous acquisition lies in
the guarantee that the volunteer is in the same state for each record-
ing modality. Recording of EEG and FMRI in separate sessions risks
adding additional variance to the data because of the potential mod-
ulation of brain responses through the environmental inﬂuence, e.g.
acoustic scanner noise, as well as variation in pharmacological re-
sponses which may vary from day to day as a result of differential
drug absorption and metabolism.
The 2-way repeated measures ANOVA reveals the inﬂuence of caf-
feine through the interaction effect of the two main factors “dosing”
(pre/post) and “drug” (placebo/caffeine). Examination of the regional
task-related BOLD signal changes (Fig. S1) suggests a partial contrib-
utor to the detected interaction effects may be an increase in BOLD re-
sponse for visual and motor tasks or a decrease for the oddball task in
the DP (post-placebo) condition compared to the BP (pre-placebo)
condition. Whilst natural variance in the data could be a source of
such apparent differences there may be a ‘time’ effect in which the
second scan of the scan day tends to differ from the ﬁrst. The second
scan of the day may be affected by the subject's expectation of a drug
effect, or altered alertness or engagement with the task, these effects
then being superimposed on the effect of caffeine. We would expect
such a time effect to be appropriately modelled by our 2-way analysis
in which the effect of caffeine is then isolated by the interaction of the
main factors.
We observed caffeine-induced alterations in physiological param-
eters in our volunteers which have the potential to alter BOLD re-
sponsiveness. Caffeine acts as a respiratory stimulant (D'Urzo et al.,
1990) causing a signiﬁcant reduction in end-tidal carbon dioxide.
This may contribute to the observed reduction in cerebral perfusion
as the brain's blood ﬂow is sensitive to arterial carbon dioxide levels.
Brown et al. (2003) have shown that such a reduction in perfusion
can give rise to an increase in BOLD contrast. However, while the di-
rection of this change is consistent with BOLD alterations we saw in
frontal regions, it is not consistent with the reductions in BOLD con-
trast in visual and motor cortex. Caffeine also caused a signiﬁcant in-
crease in systolic blood pressure. The effects of a change in baseline
blood pressure on BOLD responsiveness have not been extensively
investigated in humans. In rats, transient hypertension has been
248 A. Diukova et al. / NeuroImage 62 (2012) 239–249shown to increase BOLD signal additively with the BOLD response to a
simultaneously applied stimulus (Qiao et al., 2007). The rise in blood
pressure did not cause a larger CBF response to forepaw stimulation.
This observation combined with an expectation that autoregulation
of cerebral blood ﬂow may minimise effects of slowly changing
blood pressure, suggests that the small changes in blood pressure
seen in the current study are unlikely to alter task-related BOLD sig-
nal responsiveness.
Caffeine has the potential to alter the dynamics of the haemo-
dynamic response. It has been shown to produce an earlier BOLD
response to visual stimulation in the visual cortex (Liu et al., 2004).
Examination of the time-course of the BOLD haemodynamic response
in the present study suggested that for the visual and motor tasks
the principal caffeine effect was of a reduction in the BOLD response
amplitude. We were unable to detect a signiﬁcant caffeine-related
change in the time to 50% of the maximum BOLD response amplitude
as a marker of the timing of haemodynamic response, although our
sampling of the BOLD response was not optimised for this purpose.
A small change in timing of the haemodynamic response is unlikely
to have a large effect on our detection of changes in task related
BOLD activity using a canonical haemodynamic response function
(HRF) for the visual and motor tasks because of the block experimen-
tal design used. However, our detection of caffeine-related changes
to the event-related auditory oddball experiment with a canonical
HRF may be more sensitive to caffeine-induced changes in the HRF.
Related timing differences could be one source of our observed
caffeine effect in the BOLD signal rather than a pure modulation of
BOLD response amplitude. That is, if the model and the HRF were
temporally shifted with respect to each other, the ﬁtted model ampli-
tude would be altered. Unfortunately given the small signal changes
from the auditory oddball task and the rapid event-related design
with overlapping HRFs, it was not possible to reliably characterise
the HRF within frontal cortex to investigate alterations in HRF timing.
We suggest that the previously observed caffeine-induced 1 s tempo-
ral shift of the HRF (Liu et al., 2004) is unlikely to give rise to a
false activation in this study given that the HRF extends over ap-
proximately 10 s and that we have accounted for small shifts in
timing by including temporal derivatives in the model. Furthermore,
we also suggest that our observed frontal cortical increases in
BOLD signal with caffeine on the oddball task are likely to arise prin-
cipally from a change of BOLD response amplitude because of their
agreement with the caffeine-induced signal changes observed by
Koppelstaetter et al. (2008) who used a block-design working mem-
ory paradigm, this being less sensitive to HRF alterations than our
event-related oddball experiment.
We note several limitations of our study. Firstly, we examined
only infrequent caffeine consumers. There was no comparison with
frequent caffeine consumers which restricts our conclusions to ef-
fects of caffeine on naïve subjects. This choice was made to avoid po-
tential confounds associated with frequent caffeine consumption
(e.g., (Rogers et al., 2010)) including withdrawal effects or effects
of recent dosing on top of the experimental dose. Caffeine versus
placebo is generally found to have more marked and somewhat dif-
ferent effects on task performance, mental alertness and mood in
consumers (Rogers and Smith, 2011; Rogers et al., 2010). Secondly,
a ﬁxed dose of caffeine, not altered for body mass, was administered
to participants. This may have increased the variability of caffeine
plasma concentrations achieved (which were not measured). This
dose effect is likely to be small as we were not able to detect any
signiﬁcant correlations between bodyweight and caffeine induced
changes in blood pressure, heart rate, auditory target ERP latency,
CBF and BOLD signal. Although we conducted a motor task and
were able to measure the FMRI responses to this we were not able
to compare them with consistent EEG motor responses, partly due
to small head movements inducing artefacts in the EEG at the time
of ﬁnger tapping.Conclusion
In conclusion, our study showed improved performance on an au-
ditory oddball task. We further demonstrated using simultaneous
EEG–FMRI differential FMRI effects in infrequent caffeine consumers
of a single dose of caffeine on a cognitively engaging task, the audito-
ry oddball, compared with low-level visual and motor tasks. We sug-
gest that this differential effect is likely to reﬂect a combination of the
regional neural inﬂuence of caffeine on the cognitive task and region-
ally dependent caffeine effects on the vascular response. The use of
low-level control tasks for comparison with a more cognitively de-
manding task together with the combined use of EEG and FMRI may
help us to distinguish neural from vascular effects of caffeine. This
methodology is therefore promising for other pharmacological or dis-
ease studies in which the coupling between neural activity and the
vascular response may be altered.
Supplementary data related to this article can be found online at
doi:10.1016/j.neuroimage.2012.04.041.
Acknowledgments
AD and RGW thank the Medical Research Council UK and the
Higher Education Function Council for Wales for supporting this
study. KM thanks the Wellcome Trust for RCDF support.
References
Allen, P.J., Polizzi, G., Krakow, K., Fish, D.R., Lemieux, L., 1998. Identiﬁcation of EEG
events in the MR scanner: the problem of pulse artifact and a method for its sub-
traction. NeuroImage 8, 229–239.
Allen, P.J., Josephs, O., Turner, R., 2000. A method for removing imaging artifact from
continuous EEG recorded during functional MRI. NeuroImage 12, 230–239.
Ances, B.M., Liang, C.L., Leontiev, O., Perthen, J.E., Fleisher, A.S., Lansing, A.E., Buxton,
R.B., 2009. Effects of aging on cerebral blood ﬂow, oxygen metabolism, and blood
oxygenation level dependent responses to visual stimulation. Hum. Brain Mapp.
30, 1120–1132.
Azcona, O., Barbanoj, M.J., Torrent, J., Jane, F., 1995. Evaluation of the central effects of
alcohol and caffeine interaction. Br. J. Clin. Pharmacol. 40, 393–400.
Barry, R.J., Rushby, J.A., Wallace, M.J., Clarke, A.R., Johnstone, S.J., Zlojutro, I., 2005. Caf-
feine effects on resting-state arousal. Clin. Neurophysiol. 116, 2693–2700.
Barry, R.J., Johnstone, S.J., Clarke, A.R., Rushby, J.A., Brown, C.R., McKenzie, D.N., 2007.
Caffeine effects on ERPs and performance in an auditory Go/NoGo task. Clin. Neu-
rophysiol. 118, 2692–2699.
Bauer, A., Holschbach, M.H., Meyer, P.T., Boy, C., Herzog, H., Olsson, R.A., Coenen, H.H.,
Zilles, K., 2003. In vivo imaging of adenosine A1 receptors in the human brain with
[18F]CPFPX and positron emission tomography. NeuroImage 19, 1760–1769.
Beckmann, C.F., Jenkinson, M., Smith, S.M., 2003. General multilevel linear modeling for
group analysis in FMRI. NeuroImage 20, 1052–1063.
Bénar, C.G., Schön, D., Grimault, S., Nazarian, B., Burle, B., Roth, M., Badier, J.M., Marquis,
P., Liegeois-Chauvel, C., Anton, J.L., 2007. Single-trial analysis of oddball event-
related potentials in simultaneous EEG–fMRI. Hum. Brain Mapp. 28, 602–613.
Bendlin, B.B., Trouard, T.P., Ryan, L., 2007. Caffeine attenuates practice effects in word
stem completion as measured by fMRI BOLD signal. Hum. Brain Mapp. 28,
654–662.
Brown, G.G., Eyler Zorrilla, L.T., Georgy, B., Kindermann, S.S., Wong, E.C., Buxton, R.B.,
2003. BOLD and perfusion response to ﬁnger-thumb apposition after acetazol-
amide administration: differential relationship to global perfusion. J. Cereb. Blood
Flow Metab. 23, 829–837.
Bruce, M., Scott, N., Lader, M., Marks, V., 1986. The psychopharmacological and electro-
physiological effects of single doses of caffeine in healthy human subjects. Br. J.
Clin. Pharmacol. 22, 81–87.
Cameron, O.G., Modell, J.G., Hariharan, M., 1990. Caffeine and human cerebral blood
ﬂow: a positron emission tomography study. Life Sci. 47, 1141–1146.
Carter, C.S., Botvinick, M.M., Cohen, J.D., 1999. The contribution of the anterior cingu-
late cortex to executive processes in cognition. Rev. Neurosci. 10, 49–57.
Chen, Y., Parrish, T.B., 2009a. Caffeine dose effect on activation-induced BOLD and CBF
responses. NeuroImage 46, 577–583.
Chen, Y., Parrish, T.B., 2009b. Caffeine's effects on cerebrovascular reactivity and cou-
pling between cerebral blood ﬂow and oxygen metabolism. NeuroImage 44,
647–652.
Deslandes, A.C., Veiga, H., Cagy, M., Piedade, R., Pompeu, F., Ribeiro, P., 2004. Effects of
caffeine on visual evoked potential (P300) and neuromotor performance. Arq.
Neuropsiquiatr. 62, 385–390.
Deslandes, A.C., Veiga, H., Cagy, M., Piedade, R., Pompeu, F., Ribeiro, P., 2005. Effects of
caffeine on the electrophysiological, cognitive and motor responses of the central
nervous system. Braz. J. Med. Biol. Res. 38, 1077–1086.
Dimpfel, W., Schober, F., Spuler, M., 1993. The inﬂuence of caffeine on human EEG
under resting conditions and during mental loads. Clin. Investig. 71, 197–207.
249A. Diukova et al. / NeuroImage 62 (2012) 239–249Dixit, A., Vaney, N., Tandon, O.P., 2006. Evaluation of cognitive brain functions in
caffeine users: a P3 evoked potential study. Indian J. Physiol. Pharmacol. 50,
175–180.
Dunwiddie, T.V., Masino, S.A., 2001. The role and regulation of adenosine in the central
nervous system. Annu. Rev. Neurosci. 24, 31–55.
D'Urzo, A.D., Jhirad, R., Jenne, H., Avendano, M.A., Rubinstein, I., D'Costa, M., Goldstein,
R.S., 1990. Effect of caffeine on ventilatory responses to hypercapnia, hypoxia, and
exercise in humans. J. Appl. Physiol. 68, 322–328.
Fastbom, J., Pazos, A., Probst, A., Palacios, J.M., 1987. Adenosine A1 receptors in the
human brain: a quantitative autoradiographic study. Neuroscience 22, 827–839.
Ferre, S., 2008. An update on the mechanisms of the psychostimulant effects of caffeine.
J. Neurochem. 105, 1067–1079.
Field, A.S., Laurienti, P.J., Yen, Y.F., Burdette, J.H., Moody, D.M., 2003. Dietary caffeine
consumption and withdrawal: confounding variables in quantitative cerebral per-
fusion studies? Radiology 227, 129–135.
Fredholm, B.B., Battig, K., Holmen, J., Nehlig, A., Zvartau, E.E., 1999. Actions of caffeine in
the brain with special reference to factors that contribute to its widespread use.
Pharmacol. Rev. 51, 83–133.
Griffeth, V.E., Perthen, J.E., Buxton, R.B., 2011. Prospects for quantitative fMRI: investi-
gating the effects of caffeine on baseline oxygen metabolism and the response to a
visual stimulus in humans. NeuroImage 57, 809–816.
Haas, H.L., Selbach, O., 2000. Functions of neuronal adenosine receptors. Naunyn
Schmiedebergs Arch. Pharmacol. 362, 375–381.
Heatherley, S.V., Mullings, E.L., Tidbury, M.A., Rogers, P.J., 2006a. Caffeine consumption
among a sample of adults. Appetite 47, 266.
Heatherley, S.V., Mullings, E.L., Tidbury, M.A., Rogers, P.J., 2006b. The Dietary Caffeine and
Health Study: administration of a large postal survey in Bristol. Appetite 47, 266.
Jenkinson, M., Smith, S., 2001. A global optimisation method for robust afﬁne registra-
tion of brain images. Med. Image Anal. 5, 143–156.
Jenkinson, M., Bannister, P., Brady, M., Smith, S., 2002. Improved optimization for the
robust and accurate linear registration andmotion correction of brain images. Neu-
roImage 17, 825–841.
Kahkonen, S., Ahveninen, J., Pekkonen, E., Kaakkola, S., Huttunen, J., Ilmoniemi, R.J.,
Jaaskelainen, I.P., 2002. Dopamine modulates involuntary attention shifting and
reorienting: an electromagnetic study. Clin. Neurophysiol. 113, 1894–1902.
Kawamura, N., Maeda, H., Nakamura, J., Morita, K., Nakazawa, Y., 1996. Effects of caf-
feine on event-related potentials: comparison of oddball with single-tone para-
digms. Psychiatry Clin. Neurosci. 50, 217–221.
Kenemans, J.L., Lorist, M.M., 1995. Caffeine and selective visual processing. Pharmacol.
Biochem. Behav. 52, 461–471.
Kiehl, K.A., Laurens, K.R., Duty, T.L., Forster, B.B., Liddle, P.F., 2001. Neural sources in-
volved in auditory target detection and novelty processing: an event-related
fMRI study. Psychophysiology 38, 133–142.
Kiehl, K.A., Stevens, M.C., Laurens, K.R., Pearlson, G., Calhoun, V.D., Liddle, P.F., 2005. An
adaptive reﬂexive processing model of neurocognitive function: supporting evi-
dence from a large scale (n = 100) fMRI study of an auditory oddball task. Neuro-
Image 25, 899–915.
Koppelstaetter, F., Poeppel, T.D., Siedentopf, C.M., Ischebeck, A., Verius, M., Haala, I.,
Mottaghy, F.M., Rhomberg, P., Golaszewski, S., Gotwald, T., Lorenz, I.H., Kolbitsch,
C., Felber, S., Krause, B.J., 2008. Does caffeine modulate verbal working memory
processes? An fMRI study. NeuroImage 39, 492–499.
Latini, S., Pedata, F., 2001. Adenosine in the central nervous system: release mecha-
nisms and extracellular concentrations. J. Neurochem. 79, 463–484.
Laurienti, P.J., Field, A.S., Burdette, J.H., Maldjian, J.A., Yen, Y.F., Moody, D.M., 2002. Di-
etary caffeine consumption modulates fMRI measures. NeuroImage 17, 751–757.
Laurienti, P.J., Field, A.S., Burdette, J.H., Maldjian, J.A., Yen, Y.F., Moody, D.M., 2003. Rela-
tionship between caffeine-induced changes in resting cerebral perfusion and blood
oxygenation level-dependent signal. AJNR Am. J. Neuroradiol. 24, 1607–1611.
Lawrence, N.S., Ross, T.J., Hoffmann, R., Garavan, H., Stein, E.A., 2003. Multiple neuronal
networks mediate sustained attention. J. Cogn. Neurosci. 15, 1028–1038.
Liau, J., Perthen, J.E., Liu, T.T., 2008. Caffeine reduces the activation extent and contrast-
to-noise ratio of the functional cerebral blood ﬂow response but not the BOLD re-
sponse. NeuroImage 42, 296–305.
Liu, T., Slotnick, S.D., Serences, J.T., Yantis, S., 2003. Cortical mechanisms of feature-
based attentional control. Cereb. Cortex 13, 1334–1343.
Liu, T.T., Behzadi, Y., Restom, K., Uludag, K., Lu, K., Buracas, G.T., Dubowitz, D.J., Buxton,
R.B., 2004. Caffeine alters the temporal dynamics of the visual BOLD response. Neu-
roImage 23, 1402–1413.
Logothetis, N.K., 2008. What we can do and what we cannot do with fMRI. Nature 453,
869–878.
Lorist, M.M., Snel, J., Kok, A., Mulder, G., 1994. Inﬂuence of caffeine on selective atten-
tion in well-rested and fatigued subjects. Psychophysiology 31, 525–534.Lu, H., Clingman, C., Golay, X., van Zijl, P.C., 2004. Determining the longitudinal relaxa-
tion time (T1) of blood at 3.0 Tesla. Magn. Reson. Med. 52, 679–682.
Mattay, V.S., Callicott, J.H., Bertolino, A., Heaton, I., Frank, J.A., Coppola, R., Berman, K.F.,
Goldberg, T.E., Weinberger, D.R., 2000. Effects of dextroamphetamine on cognitive
performance and cortical activation. NeuroImage 12, 268–275.
Montenegro, M., Veiga, H., Deslandes, A., Cagy, M., McDowell, K., Pompeu, F., Piedade,
R., Ribeiro, P., 2005. Neuromodulatory effects of caffeine and bromazepam on visu-
al event-related potential (P300): a comparative study. Arq. Neuropsiquiatr. 63,
410–415.
Mulderink, T.A., Gitelman, D.R., Mesulam, M.M., Parrish, T.B., 2002. On the use of caf-
feine as a contrast booster for BOLD fMRI studies. NeuroImage 15, 37–44.
Nehlig, A., Boyet, S., 2000. Dose–response study of caffeine effects on cerebral function-
al activity with a speciﬁc focus on dependence. Brain Res. 858, 71–77.
Nelson, C.A., Luciana, M., 2001. Handbook of developmental cognitive neuroscience.
Impressions Book and Journal Services, Inc., Madison.
Owen, G., Watson, J., McGown, A., Sharma, S., Deary, I., Kerr, D., Barrett, G., 2001. Inﬂu-
ence of hypoglycaemia, with or without caffeine ingestion, on visual sensation and
performance. Clin. Sci. (Lond) 100, 619–626.
Pan, J., Takeshita, T., Morimoto, K., 2000. Acute caffeine effect on repeatedly measured
P300. Environ Health Prev. Med. 5, 13–17.
Polich, J., 2003. Overview of P3a and P3b. In: Polich, J. (Ed.), Detection of Change:
Event-Related Potential and fMRI Findings. Kluwer, Boston, pp. 83–98.
Polich, J., 2007. Updating P300: an integrative theory of P3a and P3b. Clin. Neurophy-
siol. 118, 2128–2148.
Polich, J., Herbst, K.L., 2000. P300 as a clinical assay: rationale, evaluation, and ﬁndings.
Int. J. Psychophysiol. 38, 3–19.
Qiao, M., Rushforth, D., Wang, R., Shaw, R.A., Tomanek, B., Dunn, J.F., Tuor, U.I., 2007.
Blood-oxygen-level-dependent magnetic resonance signal and cerebral oxygena-
tion responses to brain activation are enhanced by concurrent transient hyperten-
sion in rats. J. Cereb. Blood Flow Metab. 27, 1280–1289.
Rainnie, D.G., Grunze, H.C., McCarley, R.W., Greene, R.W., 1994. Adenosine inhibition of
mesopontine cholinergic neurons: implications for EEG arousal. Science 263, 689–692.
Rees, K., Allen, D., Lader, M., 1999. The inﬂuences of age and caffeine on psychomotor
and cognitive function. Psychopharmacology (Berl) 145, 181–188.
Rogers, P.J., Smith, J.E., 2011. Caffeine, mood and cognition. In: Benton, D. (Ed.), Life-
time Nutritional Inﬂuences on Cognition, Behaviour and Psychiatric Illness. Wood-
head Publishing Ltd, pp. 251–271.
Rogers, P.J., Hohoff, C., Heatherley, S.V., Mullings, E.L., Maxﬁeld, P.J., Evershed, R.P.,
Deckert, J., Nutt, D.J., 2010. Association of the anxiogenic and alerting effects of caf-
feine with ADORA2A and ADORA1 polymorphisms and habitual level of caffeine
consumption. Neuropsychopharmacology 35, 1973–1983.
Ruijter, J., De Ruiter, M.B., Snel, J., 2000a. The effects of caffeine on visual selective at-
tention to color: an ERP study. Psychophysiology 37, 427–439.
Ruijter, J., de Ruiter, M.B., Snel, J., Lorist, M.M., 2000b. The inﬂuence of caffeine on
spatial-selective attention: an event-related potential study. Clin. Neurophysiol.
111, 2223–2233.
Silvennoinen, M.J., Clingman, C.S., Golay, X., Kauppinen, R.A., van Zijl, P.C., 2003. Com-
parison of the dependence of blood R2 and R2* on oxygen saturation at 1.5 and 4.7
Tesla. Magn. Reson. Med. 49, 47–60.
Srivastava, G., Crottaz-Herbette, S., Lau, K.M., Glover, G.H., Menon, V., 2005. ICA-based
procedures for removing ballistocardiogram artifacts from EEG data acquired in
the MRI scanner. NeuroImage 24, 50–60.
Stanzione, P., Fattapposta, F., Giunti, P., D'Alessio, C., Tagliati, M., Affricano, C., Amabile,
G., 1991. P300 variations in parkinsonian patients before and during dopaminergic
monotherapy: a suggested dopamine component in P300. Electroencephalogr.
Clin. Neurophysiol. 80, 446–453.
Starkstein, S.E., Esteguy, M., Berthier, M.L., Garcia, H., Leiguarda, R., 1989. Evoked po-
tentials, reaction time and cognitive performance in on and off phases of Parkin-
son's disease. J. Neurol. Neurosurg. Psychiatry 52, 338–340.
Svenningsson, P., Hall, H., Sedvall, G., Fredholm, B.B., 1997. Distribution of adenosine
receptors in the postmortem human brain: an extended autoradiographic study.
Synapse 27, 322–335.
Wansapura, J.P., Holland, S.K., Dunn, R.S., Ball Jr., W.S., 1999. NMR relaxation times in
the human brain at 3.0 tesla. J. Magn. Reson. Imaging 9, 531–538.
Wong, E.C., Buxton, R.B., Frank, L.R., 1998. Quantitative imaging of perfusion using a
single subtraction (QUIPSS and QUIPSS II). Magn. Reson. Med. 39, 702–708.
Woolrich, M.W., Behrens, T.E., Beckmann, C.F., Jenkinson, M., Smith, S.M., 2004. Multi-
level linear modelling for FMRI group analysis using Bayesian inference. Neuro-
Image 21, 1732–1747.
Worsley, K.J., 2001. Statistical analysis of activation images. In: Jezzard, P., Matthews,
P., Smith, S. (Eds.), Functional MRI: An Introduction to Methods. Oxford University
Press, Oxford, pp. 251–270.
